Retroviral matrix and lipids, the intimate interaction

Retrovirology

Volumn 8, Issue , 2011, Pages

  Hamard Peron, Elise ^a   Muriaux, Delphine ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; MEMBRANE LIPID;

AMINO TERMINAL SEQUENCE; CELL MEMBRANE; NONHUMAN; PROTEIN DOMAIN; PROTEIN LIPID INTERACTION; RETROVIRUS; REVIEW; VIRUS ASSEMBLY; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; VIROLOGY;

ANIMALS; CELL MEMBRANE; GENE PRODUCTS, GAG; HUMANS; MEMBRANE LIPIDS; MICE; MODELS, MOLECULAR; RETROVIRIDAE; VIRUS ASSEMBLY;

EID: 79952229154     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-8-15     Document Type: Review

References (155)

1. Adamson CS, Jones IM. The molecular basis of HIV capsid assembly-five years of progress. Rev Med Virol 2004, 14(2):107-21. 10.1002/rmv.418, 15027003.
2. Darlix JL, Lapadat-Tapolsky M, de Rocquigny H, Roques BP. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. J Mol Biol 1995, 254(4):523-37. 10.1006/jmbi.1995.0635, 7500330.
3. Rein A. Retroviral RNA packaging: a review. Arch Virol Suppl 1994, 9:513-22.
4. Jouvenet N, Simon SM, Bieniasz PD. Imaging the interaction of HIV-1 genomes and Gag during assembly of individual viral particles. Proc Natl Acad Sci USA 2009, 106(45):19114-9. 10.1073/pnas.0907364106, 2776408, 19861549.
5. Ott DE, Coren LV, Shatzer T. The nucleocapsid region of human immunodeficiency virus type 1 Gag assists in the coordination of assembly and Gag processing: role for RNA-Gag binding in the early stages of assembly. J Virol 2009, 83(15):7718-27. 10.1128/JVI.00099-09, 2708646, 19457986.
6. Delelis O, Lehmann-Che J, Saïb A. Foamy viruses-a world apart. Curr Opin Microbiol 2004, 7(4):400-6. 10.1016/j.mib.2004.06.009, 15358259.
7. Choi G, Park S, Choi B, Hong S, Lee J, Hunter E, Rhee SS. Identification of a cytoplasmic targeting/retention signal in a retroviral Gag polyprotein. J Virol 1999, 73(7):5431-7. 112599, 10364290.
8. Parent LJ, Wilson CB, Resh MD, Wills JW. Evidence for a second function of the MA sequence in the Rous sarcoma virus Gag protein. J Virol 1996, 70(2):1016-26. 189907, 8551559., http://view.ncbi.nlm.nih.gov/pubmed/8551559
9. Reed M, Mariani R, Sheppard L, Pekrun K, Landau NR, Soong NW. Chimeric human immunodeficiency virus type 1 containing murine leukemia virus matrix assembles in murine cells. J Virol 2002, 76:436-43. 10.1128/JVI.76.1.436-443.2002, 135687, 11739711.
10. Chen BK, Rousso I, Shim S, Kim PS. Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cells. Proc Natl Acad Sci USA 2001, 98(26):15239-44. 10.1073/pnas.261563198, 65013, 11742097.
11. Manrique ML, Gonzalez SA, Affranchino JL. Functional relationship between the matrix proteins of feline and simian immunodeficiency viruses. Virology 2004, 329:157-67. 10.1016/j.virol.2004.07.029, 15476883.
12. Veronese FD, Copeland TD, Oroszlan S, Gallo RC, Sarngadharan MG. Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24. J Virol 1988, 62(3):795-801. 253634, 3123712.
13. Ootsuyama Y, Shimotohno K, Miwa M, Oroszlan S, Sugimura T. Myristylation of gag protein in human T-cell leukemia virus type-I and type-II. Jpn J Cancer Res 1985, 76(12):1132-5.
14. Schultz AM, Oroszlan S. In vivo modification of retroviral gag gene-encoded polyproteins by myristic acid. J Virol 1983, 46(2):355-61. 255136, 6302307.
15. Henderson LE, Krutzsch HC, Oroszlan S. Myristyl amino-terminal acylation of murine retrovirus proteins: an unusual post-translational proteins modification. Proc Natl Acad Sci USA 1983, 80(2):339-43. 10.1073/pnas.80.2.339, 393372, 6340098.
16. Rein A, McClure MR, Rice NR, Luftig RB, Schultz AM. Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc Natl Acad Sci USA 1986, 83(19):7246-50. 10.1073/pnas.83.19.7246, 386692, 3489936.
17. Massiah MA, Starich MR, Paschall C, Summers MF, Christensen AM, Sundquist WI. Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J Mol Biol 1994, 244(2):198-223. 10.1006/jmbi.1994.1719, 7966331.
18. Matthews S, Barlow P, Boyd J, Barton G, Russell R, Mills H, Cunningham M, Meyers N, Burns N, Clark N, et al. Structural similarity between the p17 matrix protein of HIV-1 and interferon-gamma. Nature 1994, 370(6491):666-8. 10.1038/370666a0, 8065455.
19. Hill CP, Worthylake D, Bancroft DP, Christensen AM, Sundquist WI. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc Natl Acad Sci USA 1996, 93(7):3099-104. 10.1073/pnas.93.7.3099, 39768, 8610175.
20. Tang C, Loeliger E, Luncsford P, Kinde I, Beckett D, Summers MF. Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc Natl Acad Sci USA 2004, 101(2):517-22. 10.1073/pnas.0305665101, 327179, 14699046.
21. Saad JS, Ablan SD, Ghanam RH, Kim A, Andrews K, Nagashima K, Soheilian F, Freed EO, Summers MF. Structure of the myristylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in membrane targeting. J Mol Biol 2008, 382(2):434-47. 10.1016/j.jmb.2008.07.027, 2581411, 18657545.
22. Rao Z, Belyaev AS, Fry E, Roy P, Jones IM, Stuart DI. Crystal structure of SIV matrix antigen and implications for virus assembly. Nature 1995, 378(6558):743-7. 10.1038/378743a0, 7501025.
23. Christensen AM, Massiah MA, Turner BG, Sundquist WI, Summers MF. Three-dimensional structure of the HTLV-II matrix protein and comparative analysis of matrix proteins from the different classes of pathogenic human retroviruses. J Mol Biol 1996, 264(5):1117-31. [Plein de refs pour trucs de base: basic residues, myr, etc HTLV-II: 4 helices alpha, une "3-10" (helice courte) patch basique]., 10.1006/jmbi.1996.0700, 9000634.
24. Matthews S, Mikhailov M, Burny A, Roy P. The solution structure of the bovine leukaemia virus matrix protein and similarity with lentiviral matrix proteins. EMBO J 1996, 15(13):3267-74. 451889, 8670827.
25. Conte MR, Klikova M, Hunter E, Ruml T, Matthews S. The three-dimensional solution structure of the matrix protein from the type D retrovirus, the Mason-Pizer monkey virus, and implications for the morphology of retroviral assembly. EMBO J 1997, 16(19):5819-26. 10.1093/emboj/16.19.5819, 1170213, 9312040.
26. McDonnell JM, Fushman D, Cahill SM, Zhou W, Wolven A, Wilson CB, Nelle TD, Resh MD, Wills J, Cowburn D. Solution structure and dynamics of the bioactive retroviral M domain from Rous sarcoma virus. J Mol Biol 1998, 279(4):921-8. 10.1006/jmbi.1998.1788, 9642071., http://view.ncbi.nlm.nih.gov/pubmed/9642071
27. Hatanaka H, Iourin O, Rao Z, Fry E, Kingsman A, Stuart DI. Structure of equine infectious anemia virus matrix protein. J Virol 2002, 76(4):1876-83. 10.1128/JVI.76.4.1876-1883.2002, 135893, 11799182.
28. Riffel N, Harlos K, Iourin O, Rao Z, Kingsman A, Stuart D, Fry E. Atomic resolution structure of Moloney murine leukemia virus matrix protein and its relationship to other retroviral matrix proteins. Structure 2002, 10(12):1627-36. 10.1016/S0969-2126(02)00896-1, 12467570.
29. Conte MR, Matthews S. Retroviral matrix proteins: a structural perspective. Virology 1998, 246(2):191-8. 10.1006/viro.1998.9206, 9657938.
30. Murray PS, Li Z, Wang J, Tang CL, Honig B, Murray D. Retroviral matrix domains share electrostatic homology: models for membrane binding function throughout the viral life cycle. Structure 2005, 13(10):1521-31. 10.1016/j.str.2005.07.010, 16216583.
31. Zhou W, Resh MD. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J Virol 1996, 70(12):8540-8. 190946, 8970978.
32. Chen K, Bachtiar I, Piszczek G, Bouamr F, Carter C, Tjandra N. Solution NMR characterizations of oligomerization and dynamics of equine infectious anemia virus matrix protein and its interaction with PIP2. Biochemistry 2008, 47(7):1928-37. 10.1021/bi701984h, 18220420.
33. Paillart JC, Gottlinger HG. Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting. J Virol 1999, 73(4):2604-12. 104015, 10074105.
34. Saad JS, Loeliger E, Luncsford P, Liriano M, Tai J, Kim A, Miller J, Joshi A, Freed EO, Summers MF. Point mutations in the HIV-1 matrix protein turn off the myristyl switch. J Mol Biol 2007, 366(2):574-85. 10.1016/j.jmb.2006.11.068, 1853300, 17188710.
35. Hansen M, Jelinek L, Whiting S, Barklis E. Transport and assembly of gag proteins into Moloney murine leukemia virus. J Virol 1990, 64(11):5306-16. 248579, 1698996.
36. Bryant M, Ratner L. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc Natl Acad Sci USA 1990, 87(2):523-7. 10.1073/pnas.87.2.523, 53297, 2405382.
37. Rhee SS, Hunter E. Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids. J Virol 1987, 61(4):1045-53. 254061, 3493352.
38. Yuan X, Yu X, Lee TH, Essex M. Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J Virol 1993, 67(11):6387-94. 238073, 8411340.
39. Freed EO, Englund G, Martin MA. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J Virol 1995, 69(6):3949-54. 189124, 7745752.
40. Ono A, Orenstein JM, Freed EO. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly. J Virol 2000, 74(6):2855-66. 10.1128/JVI.74.6.2855-2866.2000, 111776, 10684302.
41. Zhou W, Parent LJ, Wills JW, Resh MD. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J Virol 1994, 68(4):2556-69. 236733, 8139035.
42. Hamard-Peron E, Juillard F, Saad JS, Roy C, Roingeard P, Summers MF, Darlix JL, Picart C, Muriaux D. Targeting of murine leukemia virus gag to the plasma membrane is mediated by PI(4,5)P2/PS and a polybasic region in the matrix. J Virol 2010, 84:503-15. 10.1128/JVI.01134-09, 2798412, 19828619.
43. Soneoka Y, Kingsman SM, Kingsman AJ. Mutagenesis analysis of the murine leukemia virus matrix protein: identification of regions important for membrane localization and intracellular transport. J Virol 1997, 71(7):5549-59. 191797, 9188629.
44. Manrique ML, Celma CC, Gonzalez SA, Affranchino JL. Mutational analysis of the feline immunodeficiency virus matrix protein. Virus Res 2001, 76:103-13. 10.1016/S0168-1702(01)00249-0, 11376850.
45. Callahan EM, Wills JW. Repositioning basic residues in the M domain of the Rous sarcoma virus gag protein. J Virol 2000, 74(23):11222-9. 10.1128/JVI.74.23.11222-11229.2000, 113218, 11070020.
46. Le Blanc I, Rosenberg AR, Dokhelar MC. Multiple functions for the basic amino acids of the human T-cell leukemia virus type 1 matrix protein in viral transmission. J Virol 1999, 73(3):1860-7. 104426, 9971764.
47. Stansell E, Apkarian R, Haubova S, Diehl WE, Tytler EM, Hunter E. Basic residues in the Mason-Pfizer monkey virus gag matrix domain regulate intracellular trafficking and capsid-membrane interactions. J Virol 2007, 81(17):8977-88. 10.1128/JVI.00657-07, 1951391, 17596311.
48. Hoxie JA, Haggarty BS, Rackowski JL, Pillsbury N, Levy JA. Persistent noncytopathic infection of normal human T lymphocytes with AIDS-associated retrovirus. Science 1985, 229(4720):1400-2. 10.1126/science.2994222, 2994222.
49. Suomalainen M, Hultenby K, Garoff H. Targeting of Moloney murine leukemia virus gag precursor to the site of virus budding. J Cell Biol 1996, 135(6 Pt 2):1841-52. 10.1083/jcb.135.6.1841, 2133957, 8991095.
50. Benaroch P, Billard E, Gaudin R, Schindler M, Jouve M. HIV-1 assembly in macrophages. Retrovirology 2010, 7:29. 10.1186/1742-4690-7-29, 2861634, 20374631.
51. Corbin A, Grigorov B, Roingeard P, Darlix JL, Muriaux D. [Revisiting HIV-1 assembly]. Med Sci (Paris) 2008, 24:49-55. 10.1051/medsci/200824149, 18198110.
52. van Meer G, Voelker DR, Feigenson GW. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 2008, 9(2):112-24. 10.1038/nrm2330, 2642958, 18216768.
53. Cho W, Bittova L, Stahelin RV. Membrane binding assays for peripheral proteins. Anal Biochem 2001, 296(2):153-61. 10.1006/abio.2001.5225, 11554709.
54. Dalton AK, Murray PS, Murray D, Vogt VM. Biochemical characterization of rous sarcoma virus MA protein interaction with membranes. J Virol 2005, 79(10):6227-38. 10.1128/JVI.79.10.6227-6238.2005, 1091718, 15858007.
55. Dalton AK, Ako-Adjei D, Murray PS, Murray D, Vogt VM. Electrostatic interactions drive membrane association of the human immunodeficiency virus type 1 Gag MA domain. J Virol 2007, 81(12):6434-45. 10.1128/JVI.02757-06, 1900125, 17392361.
56. Ehrlich LS, Fong S, Scarlata S, Zybarth G, Carter C. Partitioning of HIV-1 Gag and Gag-related proteins to membranes. Biochemistry 1996, 35:3933-3943. 10.1021/bi952337x, 8672424.
57. Provitera P, El-Maghrabi R, Scarlata S. The effect of HIV-1 Gag myristoylation on membrane binding. Biophys Chem 2006, 119:23-32. 10.1016/j.bpc.2005.08.008, 16183191.
58. Barrera FN, Hurtado-Gomez E, Lidon-Moya MC, Neira JL. Binding of the C-terminal domain of the HIV-1 capsid protein to lipid membranes: a biophysical characterization. Biochem J 2006, 394(Pt 1):345-53. 1386033, 16259620.
59. Barrera FN, del Alamo M, Mateu MG, Neira JL. Envelope lipids regulate the in vitro assembly of the HIV-1 capsid. Biophys J 2008, 94(2):L8-10. 10.1529/biophysj.107.118083, 2157234, 17981892.
60. Provitera P, Bouamr F, Murray D, Carter C, Scarlata S. Binding of equine infectious anemia virus matrix protein to membrane bilayers involves multiple interactions. J Mol Biol 2000, 296:887-898. 10.1006/jmbi.1999.3482, 10677289.
61. Ono A, Ablan SD, Lockett SJ, Nagashima K, Freed EO. Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc Natl Acad Sci USA 2004, 101(41):14889-94. 10.1073/pnas.0405596101, 522033, 15465916.
62. Chan WT, Sherer NM, Uchil PD, Novak EK, Swank RT, Mothes W. Murine leukemia virus spreading in mice impaired in the biogenesis of secretory lysosomes and Ca2+-regulated exocytosis. PLoS ONE 2008, 3(7):e2713. 10.1371/journal.pone.0002713, 2443282, 18629000.
63. Di Paolo G, De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature 2006, 443(7112):651-7. 10.1038/nature05185, 17035995.
64. Krauss M, Haucke V. Phosphoinositides: regulators of membrane traffic and protein function. FEBS Lett 2007, 581(11):2105-11. 10.1016/j.febslet.2007.01.089, 17316616.
65. Krauss M, Haucke V. Phosphoinositide-metabolizing enzymes at the interface between membrane traffic and cell signalling. EMBO Rep 2007, 8(3):241-6. 10.1038/sj.embor.7400919, 1808040, 17330069.
66. Saad JS, Miller J, Tai J, Kim A, Ghanam RH, Summers MF. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc Natl Acad Sci USA 2006, 103(30):11364-9. 10.1073/pnas.0602818103, 1544092, 16840558.
67. Alfadhli A, Still A, Barklis E. Analysis of human immunodeficiency virus type 1 matrix binding to membranes and nucleic acids. J Virol 2009, 83(23):12196-203. 10.1128/JVI.01197-09, 2786731, 19776118.
68. Chukkapalli V, Hogue IB, Boyko V, Hu WS, Ono A. Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient gag membrane binding. J Virol 2008, 82(5):2405-17. 10.1128/JVI.01614-07, 2258911, 18094158.
69. Chukkapalli V, Oh SJ, Ono A. Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain. Proc Natl Acad Sci USA 2010, 2824378, 20080620.
70. Shkriabai N, Datta SAK, Zhao Z, Hess S, Rein A, Kvaratskhelia M. Interactions of HIV-1 Gag with assembly cofactors. Biochemistry 2006, 45(13):4077-83. 10.1021/bi052308e, 16566581.
71. Anraku K, Fukuda R, Takamune N, Misumi S, Okamoto Y, Otsuka M, Fujita M. Highly sensitive analysis of the interaction between HIV-1 Gag and phosphoinositide derivatives based on surface plasmon resonance. Biochemistry 2010, 49(25):5109-16. 10.1021/bi9019274, 20496925.
72. Valentine KG, Peterson RW, Saad JS, Summers MF, Xu X, Ames JB, Wand AJ. Reverse Micelle Encapsulation of Membrane-Anchored Proteins for Solution NMR Studies. Structure 2010, 18:9-16. 10.1016/j.str.2009.11.010, 2876244, 20152148.
73. Chan R, Uchil PD, Jin J, Shui G, Ott DE, Mothes W, Wenk MR. Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. J Virol 2008, 82(22):11228-38. 10.1128/JVI.00981-08, 2573248, 18799574., http://view.ncbi.nlm.nih.gov/pubmed/18799574
74. Ono A, Freed EO. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc Natl Acad Sci USA 2001, 98(24):13925-30. 10.1073/pnas.241320298, 61143, 11717449.
75. Brugger B, Glass B, Haberkant P, Leibrecht I, Wieland FT, Krausslich HG. The HIV lipidome: a raft with an unusual composition. Proc Natl Acad Sci USA 2006, 103(8):2641-6. 10.1073/pnas.0511136103, 1413831, 16481622.
76. Nitta T, Kuznetsov Y, McPherson A, Fan H. Murine leukemia virus glycosylated Gag (gPr80gag) facilitates interferon-sensitive virus release through lipid rafts. Proc Natl Acad Sci USA 2010, 107(3):1190-5. 10.1073/pnas.0908660107, 2824291, 20080538.
77. Cimarelli A, Luban J. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein. J Virol 1999, 73(7):5388-401. [Montre que MA interagit avec facteur+ARN]., 112595, 10364286.
78. Lochrie MA, Waugh S, Pratt DGJ, Clever J, Parslow TG, Polisky B. In vitro selection of RNAs that bind to the human immunodeficiency virus type-1 gag polyprotein. Nucleic Acids Res 1997, 25(14):2902-10. 10.1093/nar/25.14.2902, 146801, 9207041.
79. Purohit P, Dupont S, Stevenson M, Green MR. Sequence-specific interaction between HIV-1 matrix protein and viral genomic RNA revealed by in vitro genetic selection. RNA 2001, 7(4):576-84. 10.1017/S1355838201002023, 1370111, 11345436.
80. Wang H, Norris KM, Mansky LM. Involvement of the matrix and nucleocapsid domains of the bovine leukemia virus Gag polyprotein precursor in viral RNA packaging. J Virol 2003, 77(17):9431-8. 10.1128/JVI.77.17.9431-9438.2003, 187409, 12915558.
81. Parent LJ, Cairns TM, Albert JA, Wilson CB, Wills JW, Craven RC. RNA dimerization defect in a Rous sarcoma virus matrix mutant. J Virol 2000, 74:164-72. 10.1128/JVI.74.1.164-172.2000, 111525, 10590103.
82. Sherer NM, Swanson CM, Papaioannou S, Malim MH. Matrix mediates the functional link between human immunodeficiency virus type 1 RNA nuclear export elements and the assembly competency of Gag in murine cells. J Virol 2009, 83(17):8525-35. 10.1128/JVI.00699-09, 2738188, 19535446.
83. Hubner W, Chen BK. Inhibition of viral assembly in murine cells by HIV-1 matrix. Virology 2006, 352:27-38. 10.1016/j.virol.2006.04.024, 16750235.
84. Jin J, Sturgeon T, Chen C, Watkins SC, Weisz OA, Montelaro RC. Distinct intracellular trafficking of equine infectious anemia virus and human immunodeficiency virus type 1 Gag during viral assembly and budding revealed by bimolecular fluorescence complementation assays. J Virol 2007, 81(20):11226-35. 10.1128/JVI.00431-07, 2045577, 17686839.
85. Jin J, Sturgeon T, Weisz OA, Mothes W, Montelaro RC. HIV-1 matrix dependent membrane targeting is regulated by Gag mRNA tracking. PLoS One 2009, 4(8):e6551. 10.1371/journal.pone.0006551, 2717210, 19662089.
86. Chen C, Jin J, Rubin M, Huang L, Sturgeon T, Weixel KM, Stolz DB, Watkins SC, Bamburg JR, Weisz OA, Montelaro RC. Association of gag multimers with filamentous actin during equine infectious anemia virus assembly. Curr HIV Res 2007, 5(3):315-23. 10.2174/157016207780636542, 17504173.
87. Alfadhli A, Barklis RL, Barklis E. HIV-1 matrix organizes as a hexamer of trimers on membranes containing phosphatidylinositol-(4,5)-bisphosphate. Virology 2009, 387(2):466-72. 10.1016/j.virol.2009.02.048, 2680355, 19327811.
88. Hermida-Matsumoto L, Resh MD. Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55(gag) and p17MA. J Virol 1999, 73(3):1902-8. 104431, 9971769.
89. Resh MD. A myristoyl switch regulates membrane binding of HIV-1 Gag. Proc Natl Acad Sci USA 2004, 101(2):417-8. 10.1073/pnas.0308043101, 327161, 14707265.
90. Fledderman EL, Fujii K, Ghanam RH, Waki K, Prevelige PE, Freed EO, Saad JS. Myristate Exposure in the Human Immunodeficiency Virus Type 1 Matrix Protein Is Modulated by pH. Biochemistry 2010,
91. Ghanam RH, Fernandez TF, Fledderman EL, Saad JS. Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure. J Biol Chem 2010,
92. Datta SAK, Curtis JE, Ratcliff W, Clark PK, Crist RM, Lebowitz J, Krueger S, Rein A. Conformation of the HIV-1 Gag protein in solution. J Mol Biol 2007, 365(3):812-24. 10.1016/j.jmb.2006.10.073, 1866279, 17097677.
93. Datta SAK, Zhao Z, Clark PK, Tarasov S, Alexandratos JN, Campbell SJ, Kvaratskhelia M, Lebowitz J, Rein A. Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switch. J Mol Biol 2007, 365(3):799-811. 10.1016/j.jmb.2006.10.072, 1829305, 17098251.
94. Ako-Adjei D, Johnson MC, Vogt VM. The retroviral capsid domain dictates virion size, morphology, and coassembly of gag into virus-like particles. J Virol 2005, 79(21):13463-72. 10.1128/JVI.79.21.13463-13472.2005, 1262573, 16227267.
95. Crist RM, Datta SAK, Stephen AG, Soheilian F, Mirro J, Fisher RJ, Nagashima K, Rein A. Assembly properties of human immunodeficiency virus type 1 Gag-leucine zipper chimeras: implications for retrovirus assembly. J Virol 2009, 83(5):2216-25. 10.1128/JVI.02031-08, 2643709, 19073719.
96. Ono A, Freed EO. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus. J Virol 1999, 73(5):4136-44. 104193, 10196310.
97. Gerlach H, Laumann V, Martens S, Becker CFW, Goody RS, Geyer M. HIV-1 Nef membrane association depends on charge, curvature, composition and sequence. Nat Chem Biol 2010, 6:46-53. 10.1038/nchembio.268, 19935658.
98. Yezid H, Konate K, Debaisieux S, Bonhoure A, Beaumelle B. Mechanism for HIV-1 Tat insertion into the endosome membrane. J Biol Chem 2009, 284(34):22736-46. 10.1074/jbc.M109.023705, 2755682, 19549783.
99. Rayne F, Debaisieux S, Bonhoure A, Beaumelle B. HIV-1 Tat is unconventionally secreted through the plasma membrane. Cell Biol Int 2010, 34(4):409-13. 10.1042/CBI20090376, 19995346.
100. Rayne F, Debaisieux S, Yezid H, Lin YL, Mettling C, Konate K, Chazal N, Arold ST, Pugniere M, Sanchez F, Bonhoure A, Briant L, Loret E, Roy C, Beaumelle B. Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells. EMBO J 2010, 29(8):1348-62. 10.1038/emboj.2010.32, 20224549.
101. Richieri SP, Bartholomew R, Aloia RC, Savary J, Gore R, Holt J, Ferre F, Musil R, Tian HR, Trauger R, Lowry P, Jensen F, Carlo DJ, Maigetter RZ, Prior CP. Characterization of highly purified, inactivated HIV-1 particles isolated by anion exchange chromatography. Vaccine 1998, 16(2-3):119-29. 10.1016/S0264-410X(97)00196-5, 9607019.
102. Aloia RC, Jensen FC, Curtain CC, Mobley PW, Gordon LM. Lipid composition and fluidity of the human immunodeficiency virus. Proc Natl Acad Sci USA 1988, 85(3):900-4. 10.1073/pnas.85.3.900, 279664, 2829209.
103. Aloia RC, Tian H, Jensen FC. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc Natl Acad Sci USA 1993, 90(11):5181-5. 10.1073/pnas.90.11.5181, 46679, 8389472.
104. Lorizate M, Brugger B, Akiyama H, Glass B, Muller B, Anderluh G, Wieland FT, Kräusslich HG. Probing HIV-1 membrane liquid order by Laurdan staining reveals producer cell-dependent differences. J Biol Chem 2009, 284(33):22238-47. 10.1074/jbc.M109.029256, 2755948, 19553682.
105. Brugger B, Krautkrämer E, Tibroni N, Munte CE, Rauch S, Leibrecht I, Glass B, Breuer S, Geyer M, Krausslich HG, Kalbitzer HR, Wieland FT, Fackler OT. Human immunodeficiency virus type 1 Nef protein modulates the lipid composition of virions and host cell membrane microdomains. Retrovirology 2007, 4:70. 10.1186/1742-4690-4-70, 2065869, 17908312.
106. Saifuddin M, Parker CJ, Peeples ME, Gorny MK, Zolla-Pazner S, Ghassemi M, Rooney IA, Atkinson JP, Spear GT. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J Exp Med 1995, 182(2):501-9. 10.1084/jem.182.2.501, 2192116, 7543140.
107. Ott DE, Coren LV, Kane BP, Busch LK, Johnson DG, Sowder R, Chertova EN, Arthur LO, Henderson LE. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J Virol 1996, 70(11):7734-43. 190843, 8892894.
108. Chertova E, Chertov O, Coren LV, Roser JD, Trubey CM, Bess JWJ, Sowder R, Barsov E, Hood BL, Fisher RJ, Nagashima K, Conrads TP, Veenstra TD, Lifson JD, Ott DE. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J Virol 2006, 80(18):9039-52. 10.1128/JVI.01013-06, 1563931, 16940516.
109. Orentas RJ, Hildreth JE. Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res Hum Retroviruses 1993, 9(11):1157-65. 10.1089/aid.1993.9.1157, 8312057.
110. Jolly C, Sattentau QJ. Human immunodeficiency virus type 1 assembly, budding, and cell-cell spread in T cells take place in tetraspanin-enriched plasma membrane domains. J Virol 2007, 81(15):7873-84. 10.1128/JVI.01845-06, 1951303, 17522207.
111. Nydegger S, Khurana S, Krementsov DN, Foti M, Thali M. Mapping of tetraspanin-enriched microdomains that can function as gateways for HIV-1. J Cell Biol 2006, 173(5):795-807. 10.1083/jcb.200508165, 2063894, 16735575.
112. Sato K, Aoki J, Misawa N, Daikoku E, Sano K, Tanaka Y, Koyanagi Y. Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins. J Virol 2008, 82(2):1021-33. 10.1128/JVI.01044-07, 2224585, 17989173.
113. Grigorov B, Attuil-Audenis V, Perugi F, Nedelec M, Watson S, Pique C, Darlix JL, Conjeaud H, Muriaux D. A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line. Retrovirology 2009, 6:28. 10.1186/1742-4690-6-28, 2657109, 19284574.
114. Krementsov DN, Weng J, Lambele M, Roy NH, Thali M. Tetraspanins regulate cell-to-cell transmission of HIV-1. Retrovirology 2009, 6:64. 10.1186/1742-4690-6-64, 2714829, 19602278.
115. Thali M. The roles of tetraspanins in HIV-1 replication. Curr Top Microbiol Immunol 2009, 339:85-102. full_text, 20012525.
116. Krementsov DN, Rassam P, Margeat E, Roy NH, Schneider-Schaulies J, Milhiet PE, Thali M. HIV-1 assembly differentially alters dynamics and partitioning of tetraspanins and raft components. Traffic 2010,
117. Nermut MV, Wallengren K, Pager J. Localization of actin in Moloney murine leukemia virus by immunoelectron microscopy. Virology 1999, 260:23-34. 10.1006/viro.1999.9803, 10405353.
118. Ott DE, Coren LV, Johnson DG, Kane BP, Sowder R, Kim YD, Fisher RJ, Zhou XZ, Lu KP, Henderson LE. Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology 2000, 266:42-51. 10.1006/viro.1999.0075, 10612659.
119. Espenel C, Margeat E, Dosset P, Arduise C, Le Grimellec C, Royer CA, Boucheix C, Rubinstein E, Milhiet PE. Single-molecule analysis of CD9 dynamics and partitioning reveals multiple modes of interaction in the tetraspanin web. J Cell Biol 2008, 182(4):765-76. 10.1083/jcb.200803010, 2518714, 18710926.
120. Wright MD, Moseley GW, van Spriel AB. Tetraspanin microdomains in immune cell signalling and malignant disease. Tissue Antigens 2004, 64(5):533-42. 10.1111/j.1399-0039.2004.00321.x, 15496196.
121. Yang X, Kovalenko OV, Tang W, Claas C, Stipp CS, Hemler ME. Palmitoylation supports assembly and function of integrin-tetraspanin complexes. J Cell Biol 2004, 167(6):1231-40. 10.1083/jcb.200404100, 2172609, 15611341.
122. Cherukuri A, Shoham T, Sohn HW, Levy S, Brooks S, Carter R, Pierce SK. The tetraspanin CD81 is necessary for partitioning of coligated CD19/CD21-B cell antigen receptor complexes into signaling-active lipid rafts. J Immunol 2004, 172:370-80.
123. Cherukuri A, Carter RH, Brooks S, Bornmann W, Finn R, Dowd CS, Pierce SK. B cell signaling is regulated by induced palmitoylation of CD81. J Biol Chem 2004, 279(30):31973-82. 10.1074/jbc.M404410200, 15161911.
124. Delaguillaumie A, Harriague J, Kohanna S, Bismuth G, Rubinstein E, Seigneuret M, Conjeaud H. Tetraspanin CD82 controls the association of cholesterol-dependent microdomains with the actin cytoskeleton in T lymphocytes: relevance to co-stimulation. J Cell Sci 2004, 117(Pt 22):5269-82. 10.1242/jcs.01380, 15454569.
125. Munro S. Lipid rafts: elusive or illusive?. Cell 2003, 115(4):377-88. 10.1016/S0092-8674(03)00882-1, 14622593.
126. Simons K, Vaz WLC. Model systems, lipid rafts, and cell membranes. Annu Rev Biophys Biomol Struct 2004, 33:269-95. 10.1146/annurev.biophys.32.110601.141803, 15139814.
127. Zech T, Ejsing CS, Gaus K, de Wet B, Shevchenko A, Simons K, Harder T. Accumulation of raft lipids in T-cell plasma membrane domains engaged in TCR signalling. EMBO J 2009, 28(5):466-76. 10.1038/emboj.2009.6, 2657588, 19177148.
128. Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science 2010, 327(5961):46-50. 10.1126/science.1174621, 20044567.
129. Campbell S, Gaus K, Bittman R, Jessup W, Crowe S, Mak J. The raft-promoting property of virion-associated cholesterol, but not the presence of virion-associated Brij 98 rafts, is a determinant of human immunodeficiency virus type 1 infectivity. J Virol 2004, 78(19):10556-65. 10.1128/JVI.78.19.10556-10565.2004, 516414, 15367622.
130. Ding L, Derdowski A, Wang JJ, Spearman P. Independent segregation of human immunodeficiency virus type 1 Gag protein complexes and lipid rafts. J Virol 2003, 77(3):1916-26. 10.1128/JVI.77.3.1916-1926.2003, 140875, 12525626.
131. Halwani R, Khorchid A, Cen S, Kleiman L. Rapid localization of Gag/GagPol complexes to detergent-resistant membrane during the assembly of human immunodeficiency virus type 1. J Virol 2003, 77(7):3973-84. 10.1128/JVI.77.7.3973-3984.2003, 150626, 12634357.
132. Holm K, Weclewicz K, Hewson R, Suomalainen M. Human immunodeficiency virus type 1 assembly and lipid rafts: Pr55(gag) associates with membrane domains that are largely resistant to Brij98 but sensitive to Triton X-100. J Virol 2003, 77(8):4805-17. 10.1128/JVI.77.8.4805-4817.2003, 152122, 12663787.
133. Lindwasser OW, Resh MD. Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains. J Virol 2001, 75(17):7913-24. 10.1128/JVI.75.17.7913-7924.2001, 115035, 11483736.
134. Nguyen DH, Hildreth JE. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol 2000, 74(7):3264-72. 10.1128/JVI.74.7.3264-3272.2000, 111827, 10708443.
135. Ono A, Waheed AA, Freed EO. Depletion of cellular cholesterol inhibits membrane binding and higher-order multimerization of human immunodeficiency virus type 1 Gag. Virology 2007, 360:27-35. 10.1016/j.virol.2006.10.011, 1945131, 17095032.
136. Pickl WF, Pimentel-Muïnos FX, Seed B. Lipid rafts and pseudotyping. J Virol 2001, 75(15):7175-83. 10.1128/JVI.75.15.7175-7183.2001, 114446, 11435598.
137. Bhattacharya J, Repik A, Clapham PR. Gag regulates association of human immunodeficiency virus type 1 envelope with detergent-resistant membranes. J Virol 2006, 80(11):5292-300. 10.1128/JVI.01469-05, 1472128, 16699009.
138. Feng X, Heyden NV, Ratner L. Alpha interferon inhibits human T-cell leukemia virus type 1 assembly by preventing Gag interaction with rafts. J Virol 2003, 77(24):13389-95. 10.1128/JVI.77.24.13389-13395.2003, 296084, 14645593.
139. Lingwood D, Kaiser HJ, Levental I, Simons K. Lipid rafts as functional heterogeneity in cell membranes. Biochem Soc Trans 2009, 37(Pt 5):955-60. 10.1042/BST0370955, 19754431.
140. Ono A. HIV-1 Assembly at the Plasma Membrane: Gag Trafficking and Localization. Future Virol 2009, 4(3):241-257. 10.2217/fvl.09.4, 2676728, 19802344.
141. Waheed AA, Freed EO. Lipids and membrane microdomains in HIV-1 replication. Virus Res 2009, 143(2):162-76. 10.1016/j.virusres.2009.04.007, 2731011, 19383519.
142. Ono A, Waheed AA, Joshi A, Freed EO. Association of human immunodeficiency virus type 1 gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel Gag multimerization assay. J Virol 2005, 79(22):14131-40. 10.1128/JVI.79.22.14131-14140.2005, 1280195, 16254348.
143. Johnson CM, Chichili GR, Rodgers W. Compartmentalization of phosphatidylinositol 4,5-bisphosphate signaling evidenced using targeted phosphatases. J Biol Chem 2008, 283(44):29920-8. 10.1074/jbc.M805921200, 2573053, 18723502.
144. Harrist AV, Ryzhova EV, Harvey T, Gonzalez-Scarano F. Anx2 interacts with HIV-1 Gag at phosphatidylinositol (4,5) bisphosphate-containing lipid rafts and increases viral production in 293T cells. PLoS One 2009, 4(3):e5020. 10.1371/journal.pone.0005020, 2657825, 19325895.
145. Chasserot-Golaz S, Vitale N, Umbrecht-Jenck E, Knight D, Gerke V, Bader MF. Annexin 2 promotes the formation of lipid microdomains required for calcium-regulated exocytosis of dense-core vesicles. Mol Biol Cell 2005, 16(3):1108-19. 10.1091/mbc.E04-07-0627, 551477, 15635098.
146. Menke M, Gerke V, Steinem C. Phosphatidylserine membrane domain clustering induced by annexin A2/S100A10 heterotetramer. Biochemistry 2005, 44(46):15296-303. 10.1021/bi051585i, 16285733.
147. Zheng YH, Plemenitas A, Linnemann T, Fackler OT, Peterlin BM. Nef increases infectivity of HIV via lipid rafts. Curr Biol 2001, 11(11):875-9. 10.1016/S0960-9822(01)00237-8, 11516650.
148. Zheng YH, Plemenitas A, Fielding CJ, Peterlin BM. Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions. Proc Natl Acad Sci USA 2003, 100(14):8460-5. 10.1073/pnas.1437453100, 166251, 12824470.
149. Pique C, Lagaudrielare-Gesbert C, Delamarre L, Rosenberg AR, Conjeaud H, Dokhelar MC. Interaction of CD82 tetraspanin proteins with HTLV-1 envelope glycoproteins inhibits cell-to-cell fusion and virus transmission. Virology 2000, 276(2):455-65. 10.1006/viro.2000.0538, 11040136.
150. Mazurov D, Heidecker G, Derse D. HTLV-1 Gag protein associates with CD82 tetraspanin microdomains at the plasma membrane. Virology 2006, 346:194-204. 10.1016/j.virol.2005.10.033, 16325219.
151. Mazurov D, Heidecker G, Derse D. The inner loop of tetraspanins CD82 and CD81 mediates interactions with human T cell lymphotrophic virus type 1 Gag protein. J Biol Chem 2007, 282(6):3896-903. 10.1074/jbc.M607322200, 17166843.
152. Ruiz-Mateos E, Pelchen-Matthews A, Deneka M, Marsh M. CD63 is not required for production of infectious human immunodeficiency virus type 1 in human macrophages. J Virol 2008, 82(10):4751-61. 10.1128/JVI.02320-07, 2346747, 18321974.
153. Hemler ME. Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 2005, 6(10):801-11. 10.1038/nrm1736, 16314869.
154. Chichili GR, Westmuckett AD, Rodgers W. T cell signal regulation by the actin cytoskeleton. J Biol Chem 2010, 285(19):14737-46. 10.1074/jbc.M109.097311, 20194498.
155. Strasner AB, Natarajan M, Doman T, Key D, August A, Henderson AJ. The Src kinase Lck facilitates assembly of HIV-1 at the plasma membrane. J Immunol 2008, 181(5):3706-13. 2587142, 18714047.